Immunotherapy News and Research

Latest Immunotherapy News and Research

Medicaid expansion increases cancer clinical trial participation

Medicaid expansion increases cancer clinical trial participation

New artificial DNA structures can target and destroy cancer cells

New artificial DNA structures can target and destroy cancer cells

Lorazepam linked to shorter progression-free survival in pancreatic cancer patients

Lorazepam linked to shorter progression-free survival in pancreatic cancer patients

Immunotherapy combination extends progression-free survival in patients with melanoma

Immunotherapy combination extends progression-free survival in patients with melanoma

Researchers receive DoD grant to target chemotherapy resistance in pancreatic cancer

Researchers receive DoD grant to target chemotherapy resistance in pancreatic cancer

Rutgers scientists discover first lipid vascular 'zip code' in the lungs

Rutgers scientists discover first lipid vascular 'zip code' in the lungs

Early lung cancer detection with a machine learning model based on imaging, clinical, and DNA methylation biomarkers

Early lung cancer detection with a machine learning model based on imaging, clinical, and DNA methylation biomarkers

Deep learning framework DeepAIR could improve understanding of adaptive immunity

Deep learning framework DeepAIR could improve understanding of adaptive immunity

Peripheral tumor biomarkers to guide treatment for HPV-associated malignancies

Peripheral tumor biomarkers to guide treatment for HPV-associated malignancies

Oncolytic viruses could be used to 'warm up' cold tumors and improve immunotherapy

Oncolytic viruses could be used to 'warm up' cold tumors and improve immunotherapy

Scientists identify key proteins driving cancer across multiple tumor types

Scientists identify key proteins driving cancer across multiple tumor types

Researchers design one-step procedure for improving effective of adoptive cell immunotherapy against solid tumors

Researchers design one-step procedure for improving effective of adoptive cell immunotherapy against solid tumors

What is the prevalence of current alcohol consumption and of risky alcohol consumption among cancer survivors in the US?

What is the prevalence of current alcohol consumption and of risky alcohol consumption among cancer survivors in the US?

Salk scientists find new immunotherapy treatment for glioblastoma

Salk scientists find new immunotherapy treatment for glioblastoma

Gut microbiota could affect the responsiveness and efficacy of cancer treatment

Gut microbiota could affect the responsiveness and efficacy of cancer treatment

A drug for heart conditions improves efficacy of melanoma therapies

A drug for heart conditions improves efficacy of melanoma therapies

Study explores the diverse expression patterns of T cell priming markers across cancers

Study explores the diverse expression patterns of T cell priming markers across cancers

Immunotherapy after stem cell transplantation effectively combats certain childhood nerve tumors

Immunotherapy after stem cell transplantation effectively combats certain childhood nerve tumors

Deep-learning technology could help scientists to develop personalized immunotherapies and vaccines

Deep-learning technology could help scientists to develop personalized immunotherapies and vaccines

Researchers develop antibody drugs from tobacco plants for cancer treatment

Researchers develop antibody drugs from tobacco plants for cancer treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.